Heterotopic Heart Transplantation: The United States Experience

Authors

  • Jama Jahanyar
  • Michael M. Koerner
  • Ali Ghodsizad
  • Matthias Loebe
  • George P. Noon

DOI:

https://doi.org/10.1532/HSF98.2014328

Abstract

Introduction: More than 3 decades have passed since the first heterotopic heart transplantation (HHT) was reported. Nowadays, this surgical technique is used rarely, and only in patients who do not qualify for standard orthotopic heart transplantation (OHT). Current indications mainly comprise refractory pulmonary hypertension and a donor-recipient size mismatch (>20%). The objective of this study was to analyze the United States experience with HHT.

Patients and Methods: The United Network for Organ Sharing (UNOS) database between 1987 and 2007 was analyzed. Patients who underwent heart transplantation were enrolled in this study. Patients with missing transplant dates or history of retransplantation were excluded.

Results: A total of 41,379 patients underwent OHT and 178 HHT; 32,361 and 111 patients, respectively, were enrolled. Overall 1-, 5-, and 10-year survival was significantly (P < .001) better in OHT (87.7%, 74.4%, 54.4%) than HHT patients (83.8%, 59%, 35.1%). Survival in patients with transpulmonary gradients (TPG) >15 mmHg was 86.6 %, 73.3%, and 57.4% in the OHT and 93.8%, 64.8%, and 48.6% in the HHT group (P = .35). Pretransplant criteria (HHT versus OHT) with statistically significant differences (P < .05) were as follows (mean + SD): recipient weight, 78.9 + 19.9 versus 74.1 + 23.4 kg; recipient height, 174.9 + 13.9 versus 168 + 25.1 cm; and TPG 12.1 + 7.2 versus 9.6 + 6.3 mmHg.

Conclusions: The results show that HHT remains a feasible option in a highly selected patient population, with overall good results.

References

Alexopoulos D, Sleight P, Yacoub MH. 1988. Supraventricular tachycardia after heterotopic heart transplantation. Eur Heart J 9:1266-8.nAnyanwu AC, Banner NR, Radley-Smith R, Khaghani A, Yacoub MH. 2002. Long-term results of cardiac transplantation from live donors: the domino heart transplant. J Heart Lung Transplant 21:971-5.nBarnard CN. 1967. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 41:1271-4.nBarnard CN, Losman JG. 1975. Left ventricular bypass. S Afr Med J 49:303-12.nBarnard CN, Losman JG, Curcio CA, Sanchez HE, Wolpowitz A, Barnard MS. 1977. The advantage of heterotopic cardiac transplantation over orthotopic cardiac transplantation in the management of severe acute rejection. J Thorac Cardiovasc Surg 74:918-24.nBarnard CN, Wolpowitz A. 1979. Heterotopic versus orthotopic heart transplantation. Transplant Proc 11:309-12.nChapelier A, Vouhe P, Macchiarini P, et al. 1993. Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 106:299-307.nChiu KM, Lin TY, Chu SH. 2006. Successful heterotopic heart transplant after cardiopulmonary bypass rescue of an arrested donor heart. Transplant Proc 38:1514-5.nCooper DK, Novitzky D, Becerra E, Reichart B. 1986. Are there indications for heterotopic heart transplantation in 1986? A 2- to 11-year follow-up of 49 consecutive patients undergoing heterotopic heart transplantation. Thorac Cardiovasc Surg 34:300-4.nDesruennes M, Muneretto C, Gandjbakhch I, et al. 1989. Heterotopic heart transplantation: current status in 1988. J Heart Transplant 8:479-85.nEtz CD, Welp HA, Tjan TD, et al. 2007. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg 83:1697-705.nKawaguchi A, Gandjbakhch I, Pavie A, et al. 1989. Cardiac transplant recipients with preoperative pulmonary hypertension. Evolution of pulmonary hemodynamics and surgical options. Circulation 80(5 Pt 2):III90-6.nKawaguchi A, Gandjbakhch I, Pavie A, et al. 1989. Factors affecting survival after heterotopic heart transplantation. J Thorac Cardiovasc Surg 98(5 Pt 2):928-34.nKonertz W, Sheikhzadeh A, Weyand M, Friedl A, Bernhard A. 1988. Heterotopic heart transplantation: current indications for the procedure, with results in 10 patients. Tex Heart Inst J 15:159-62.nKotliar C, Smart FW, Sekela ME, et al. 1991. Heterotopic heart transplantation and native heart ventricular arrhythmias. Ann Thorac Surg 51:987-91.nLivi U, Faggian G, Chiominto B, Mazzucco A, Bortolotti U, Gallucci V. 1990. Heterotopic heart transplantation-a means to increase donor availability. Eur J Cardiothorac Surg 4:202-6.nMangoush O, Bahrami T, De Robertis F, et al. 2004. Regurgitation of the native aortic valve caused by thrombus formation after heterotopic heart transplantation. Ann Thorac Surg 78:1821-3.nMartin J, Siegenthaler MP, Friesewinkel O, et al. 2004. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study. Eur J Cardiothorac Surg 25:971-7.nMcMullan DM, Wilansky S, Frazier OH. 2003. Ventricular fibrillation in a heterotopic heart transplant recipient. Ann Thorac Surg 75:598.nNakatani T, Frazier OH, Lammermeier DE, Macris MP, Radovancevic B. 1989. Heterotopic heart transplantation: a reliable option for a select group of high-risk patients. J Heart Transplant 8:40-7.nNewcomb AE, Esmore DS, Rosenfeldt FL, Richardson M, Marasco SF. 2004. Heterotopic heart transplantation: an expanding role in the twenty-first century? Ann Thorac Surg 78:1345-50; discussion 1350-1.nNovitzky D, Cooper DK, Rose AG, Barnard CN. 1984. The value of recipient heart assistance during severe acute rejection following heterotopic cardiac transplantation. J Cardiovasc Surg 25:287-95.nReichenspurner H, Hildebrandt A, Boehm D, et al. 1989. Heterotopic heart transplantation in 1988: recent selective indications and outcome. J Heart Transplant 8:381-6.nRidley PD, Khaghani A, Musumeci F, et al. 1992. Heterotopic heart transplantation and recipient heart operation in ischemic heart disease. Ann Thorac Surg 54:333-7.nRose EA, Gelijns AC, Moskowitz AJ, et al. 2001. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345:1435-43.nSalzberg SP, Lachat ML, von Harbou K, Zund G, Turina MI. 2005. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg 27:222-5.nTagusari O, Kormos RL, Kawai A, et al. 1999. Native heart complications after heterotopic heart transplantation: insight into the potential risk of left ventricular assist device. J Heart Lung Transplant 18:1111-9.nVillanueva FS, Murali S, Uretsky BF, et al. 1989. Resolution of severe pulmonary hypertension after heterotopic cardiac transplantation. J Am Coll Cardiol 14:1239-43.nZimpfer D, Zrunek P, Sandner S, et al. 2007. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg 31:698-702.n

Published

2014-07-03

How to Cite

Jahanyar, J., Koerner, M. M., Ghodsizad, A., Loebe, M., & Noon, G. P. (2014). Heterotopic Heart Transplantation: The United States Experience. The Heart Surgery Forum, 17(3), E132-E140. https://doi.org/10.1532/HSF98.2014328

Issue

Section

Articles

Most read articles by the same author(s)

1 2 3 > >>